Chronic Obstructive Pulmonary Disease (COPD) is one of the most serious lung diseases prevalent today affecting 65 million people worldwide.
From moderate chronic bronchitis to severe emphysema, COPD covers a range of debilitating lung conditions that limit airflow to the lungs.
The World Health Organisation (WHO) recognises that bronchodilator medications are crucial for symptomatic management of COPD and to effectively treat severe exacerbations of the disease.
Aerogen’s ground breaking technology and high performance aerosol drug delivery systems, the Aerogen Solo & the Aerogen Ultra, provide patients with quick and effective respiratory care at all stages of COPD.
Every day, millions of lives worldwide are affected by asthma. Difficulties in breathing mean serious health concerns and challenge the daily activities of sufferers with this respiratory condition. Healthcare experts realise that this global epidemic needs effective medical treatment:
Aerogen’s ground breaking technology and high performance aerosol drug delivery systems, the Aerogen Solo & the Aerogen Ultra give targeted respiratory relief to asthmatics regardless of the severity of their condition.
Bronchodilators relax the muscle around your airways and are used to ease chest tightness. They can prepare your chest for chest physiotherapy or exercise by opening your airways.
Antibiotics are used to treat, prevent and control infection. They should be taken after bronchodilators and chest physiotherapy.
DNase is used to make sputum thinner and easier to clear. It is normally prescribed once a day.
Hypertonic sodium chloride comes in different strengths; 3%, 6% or 7%. You may also know it as Nebusal® or Mucoclear®. It draws more water into the airways and sputum in the lung.
It is not common for people with cystic fibrosis to need aerosol delivered corticosteroids
Antifungals reduce the amount of fungal growth in the lungs. It is not common to nebulise antifungals but the CF team may ask patients to do this in certain circumstances.